Suppr超能文献

ACE I/D多态性对血液透析患者血浆纤溶酶原激活物抑制剂1、D-二聚体、超敏C反应蛋白及转化生长因子β1水平的影响

Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis.

作者信息

de Carvalho Sara Santos, Simões e Silva Ana Cristina, Sabino Adriano de Paula, Evangelista Fernanda Cristina Gontijo, Gomes Karina Braga, Dusse Luci Maria SantAna, Rios Danyelle Romana Alves

机构信息

Campus Centro Oeste Dona Lindu, Universidade Federal de São João del-Rei, Divinópolis/MG - Brazil.

Department of Pediatrics, Interdisciplinary Laboratory of Medical Investigation, Faculty of Medicine - Universidade Federal de Minas Gerais, Belo Horizonte/MG - Brazil.

出版信息

PLoS One. 2016 Mar 29;11(3):e0150613. doi: 10.1371/journal.pone.0150613. eCollection 2016.

Abstract

BACKGROUND

There is substantial evidence that chronic renal and cardiovascular diseases are associated with coagulation disorders, endothelial dysfunction, inflammation and fibrosis. Angiotensin-Converting Enzyme Insertion/Deletion polymorphism (ACE I/D polymorphism) has also be linked to cardiovascular diseases. Therefore, this study aimed to compare plasma levels of ultrassensible C-reactive protein (usCRP), PAI-1, D-dimer and TGF-β1 in patients undergoing HD with different ACE I/D polymorphisms.

METHODS

The study was performed in 138 patients at ESRD under hemodialysis therapy for more than six months. The patients were divided into three groups according to the genotype. Genomic DNA was extracted from blood cells (leukocytes). ACE I/D polymorphism was investigated by single polymerase chain reaction (PCR). Plasma levels of D-dimer, PAI-1 and TGF-β1 were measured by enzyme-linked immunosorbent assay (ELISA), and the determination of plasma levels of usCRP was performed by immunonephelometry. Data were analyzed by the software SigmaStat 2.03.

RESULTS

Clinical characteristics were similar in patients with these three ACE I/D polymorphisms, except for interdialytic weight gain. I allele could be associated with higher interdialytic weight gain (P = 0.017). Patients genotyped as DD and as ID had significantly higher levels of PAI-1 than those with II genotype. Other laboratory parameters did not significantly differ among the three subgroups (P = 0.033). Despite not reaching statistical significance, plasma levels of usCRP were higher in patients carrying the D allele.

CONCLUSION

ACE I/D polymorphisms could be associated with changes in the regulation of sodium, fibrinolytic system, and possibly, inflammation. Our data showed that high levels of PAI-1 are detected when D allele is present, whereas greater interdialytic gain is associated with the presence of I allele. However, further studies with different experimental designs are necessary to elucidate the mechanisms involved in these associations.

摘要

背景

有大量证据表明,慢性肾脏疾病和心血管疾病与凝血功能障碍、内皮功能障碍、炎症及纤维化相关。血管紧张素转换酶插入/缺失多态性(ACE I/D多态性)也与心血管疾病有关。因此,本研究旨在比较不同ACE I/D多态性的血液透析患者的超敏C反应蛋白(usCRP)、纤溶酶原激活物抑制剂-1(PAI-1)、D-二聚体和转化生长因子-β1(TGF-β1)的血浆水平。

方法

本研究纳入了138例接受血液透析治疗超过6个月的终末期肾病(ESRD)患者。根据基因型将患者分为三组。从血细胞(白细胞)中提取基因组DNA。通过单聚合酶链反应(PCR)检测ACE I/D多态性。采用酶联免疫吸附测定(ELISA)法检测血浆D-二聚体、PAI-1和TGF-β1水平,采用免疫比浊法测定血浆usCRP水平。数据采用SigmaStat 2.03软件进行分析。

结果

除透析间期体重增加外,这三种ACE I/D多态性患者的临床特征相似。I等位基因可能与更高的透析间期体重增加有关(P = 0.017)。基因型为DD和ID的患者PAI-1水平显著高于II基因型患者。其他实验室参数在三个亚组之间无显著差异(P = 0.033)。尽管未达到统计学意义,但携带D等位基因的患者血浆usCRP水平较高。

结论

ACE I/D多态性可能与钠调节、纤维蛋白溶解系统的变化以及可能的炎症反应有关。我们的数据显示,当存在D等位基因时可检测到高水平的PAI-1,而更大的透析间期体重增加与I等位基因的存在有关。然而,需要采用不同实验设计的进一步研究来阐明这些关联中涉及的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验